Federal Register / Vol. 88, No. 236 / Monday, December 11, 2023 / Notices 85887 

requirement accommodates required 

updates to FBO reporting systems. 

Commenters also recommended 

retaining the option for FBOs to file the 

FR Y–7Q on a fiscal year basis. 

Commenters stated that FBOs that 

follow a non-calendar fiscal year base 

their home country reporting 

requirements, internal and external 

financial reporting, and management 

information systems around the 90-day 

filing deadline for the FR Y–7Q. 

In response to the comments received, 

the Board will move forward with a 

modified approach so that only the 

following three items that capture U.S. 

assets would be required to be filed on 

a calendar period basis: Line item 6(a)— 

Total combined U.S. assets net of 

intercompany balances and 

transactions; Line item 6(b)—Total 

combined U.S. assets net of 

intercompany balances and 

transactions, based on a quarterly 

average; and Line item 7—Total onbranch assets. The remaining line items 

on the FRY–7Q will continue to be 

collected with fiscal filing as an option. 

The Board has also decided to retain 

line item 8, as-of financial date, in Part 

1A and line item 6, as-of financial date, 

in Part 2, in order to continue the use 

of the fiscal filing option, which will 

only apply to non-U.S. asset line items. 

FR Y–7Q respondents that are required 

to file the FR Y–15 would have already 

submitted total combined U.S. assets net 

of intercompany balances and 

transactions, given that the FR Y–15 is 

due 50 calendar days after March 31, 

June 30 and September 30, and 65 days 

after December 31. Individual 

respondents that believe the information 

they are required to submit under the 

FR Y–7Q is nonpublic commercial or 

financial information, which is both 

customarily and treated as private by 

the respondent, may request 

confidential treatment of such 

information under exemption 4 of the 

FOIA. 

Finally, commenters expressed 

concern about shortening the filing 

deadline for the FR Y–7Q because firms 

may need more than 30 days to provide 

capital adequacy information to their 

home country supervisor before they 

report it on the FR Y–7Q. Commenters 

stated that modifying home country 

reporting frameworks to file the 

information on an accelerated timetable 

based on the FR Y–7Q would require 

significant resources. 

In response to the comments received, 

the Board has modified the proposal to 

stagger implementation filing deadlines. 

The modified proposal would be 

implemented in two phases. Under 

phase one, effective as of December 31, 

2023, all FR Y–7Q filers that file the FR 

Y–15 would report no later than 70 days 

after the report date. The remaining 

filers would have 90 days to file the FR 

Y–7Q after calendar end. Under phase 

two, effective as of December 31, 2024, 

all remaining FR Y–7Q filers would 

report no later than 70 days after the 

report date. Moving this implementation 

date to December 31, 2024, from the 

originally proposed December 31, 2022, 

would allow additional time for 

respondents to implement the necessary 

system enhancements. Further, fiscal 

filers with a report date after the 

calendar quarter-end periods (e.g. 

January 31, April 30, July 31 and 

October 31) inherently have additional 

time to submit the FR Y–7Q. 

Board of Governors of the Federal Reserve 

System, December 5, 2023. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–27055 Filed 12–8–23; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–1385; Docket No. CDC–2024– 

0098] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Characteristics 

of Cases of Priority Fungal Diseases. 

These case report forms (CRFs) collect 

information on patient demographics, 

underlying conditions, diagnosis, 

treatments, healthcare utilization, and 

outcomes of patients with 

coccidioidomycosis, histoplasmosis, 

blastomycosis, Candida auris, triazoleresistant Aspergillus fumigatus infection 

or colonization, or antifungal-resistant 

dermatophytosis. 

DATES: CDC must receive written 

comments on or before February 9, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0098 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 


lotter on DSK11XQN23PROD with NOTICES1
85888 Federal Register / Vol. 88, No. 236 / Monday, December 11, 2023 / Notices 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Characteristics of Cases of Priority 

Fungal Diseases (OMB Control No. 

0920–1385, Exp. 3/31/2026)— 

Revision—National Center for Emerging 

and Zoonotic Infectious Diseases 

(NCEZID), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

Fungal diseases cause substantial 

illness, ranging from mild infection to 

severe or life-threatening invasive 

disease. They also constitute a 

considerable financial burden on 

patients and healthcare systems. 

Awareness of fungal diseases is low, 

and data collection has historically been 

limited in size, scope, and coordination, 

which has hindered our understanding 

of these diseases. Detailed 

epidemiologic and clinical data are 

critical to inform appropriate public 

health responses. 

We plan to enhance surveillance of 

high priority fungal diseases across the 

United States to better characterize 

factors such as disease burden, 

geographic scope, patient risk factors, 

health disparities, healthcare utilization, 

outcomes, and emerging trends. This 

project will serve as a Revision of the 

information collections project: 

Triazole-resistant Aspergillus fumigatus 

Case Report Form (CRF). The Revision 

will expand the number of fungal 

diseases for which data may be 

collected. In addition to triazoleresistant A. fumigatus infections, CRFs 

have also been developed for 

coccidioidomycosis, histoplasmosis, 

blastomycosis, C. auris, and antifungalresistant dermatophytosis. CDC is also 

changing the name of this information 

collections project from Triazoleresistant Aspergillus fumigatus Case 

Report Form to Characteristics of Cases 

of Priority Fungal Diseases. 

We plan to use standardized CRFs to 

collect public health surveillance data 

for cases of these diseases regarding 

demographics (e.g., age, sex, race/ 

ethnicity, location of residence), 

underlying medical conditions, 

diagnosis (e.g., clinical presentation, 

laboratory testing), treatments, and 

outcomes (e.g., hospitalization, vital 

status). The corresponding CRF would 

be filled out voluntarily by State and 

local health departments and contains a 

section for medical chart review and an 

optional supplemental interview 

(including data on potential 

occupational or environmental 

exposures) of the patient or their 

representative. Findings can help 

identify populations at higher risk of 

these diseases, detect emerging 

epidemiologic trends, and guide 

prevention and response efforts. They 

can also help better focus public and 

healthcare provider outreach, inform 

efforts to contain or mitigate spread, and 

influence health policy and research on 

prevention and treatment. 

CDC requests OMB approval for an 

estimated 1,138 annual burden hours. 

There is no cost to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

State and Local Health Departments Characteristics of Patients with Environmentally-derived Triazole-resistant Aspergillus fumigatus.15 15 30/60 113 

State and Local Health Departments Characteristics of Patients with Coccidioidomycosis.10 25 1 250 

State and Local Health Departments Characteristics of Patients with 

Histoplasmosis.

10 25 1 250 

State and Local Health Departments Characteristics of Patients with Blastomycosis.10 25 1 250 

State and Local Health Departments Characteristics of Patients with Candida 

auris.

15 20 45/60 225 

State and Local Health Departments Characteristics of Patients with Antifungal-resistant Dermatophytosis.10 10 30/60 50 

Total ............................................ ........................................................................ .................... ........................ .................... 1,138 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–27081 Filed 12–8–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–24BJ; Docket No. CDC–2023– 

0097] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled DP–23–0002 

Healthy Schools Evaluation. The project 


lotter on DSK11XQN23PROD with NOTICES1